{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:16:47Z","timestamp":1765808207988,"version":"3.37.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00277-023-05191-9","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T20:29:12Z","timestamp":1686083352000},"page":"1121-1129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?"],"prefix":"10.1007","volume":"103","author":[{"given":"Shahrukh K.","family":"Hashmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray C.","family":"Powles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7156-2532","authenticated-orcid":false,"given":"Ibrahim N.","family":"Muhsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietger","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Weisdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mickey B. C.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildegard","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"5191_CR1","doi-asserted-by":"crossref","unstructured":"The Lancet Oncology (2022) Conflict in Ukraine and its impact on cancer care. Lancet Oncol 23(4):439","DOI":"10.1016\/S1470-2045(22)00149-8"},{"key":"5191_CR2","doi-asserted-by":"crossref","unstructured":"Kizub D, Melnitchouk N, Beznosenko A, Shabat G, Semeniv S, Nogueira L, et al (2022) Resilience and perseverance under siege: providing cancer care during the invasion of Ukraine. Lancet Oncol 23(5):579\u2013583","DOI":"10.1016\/S1470-2045(22)00189-9"},{"key":"5191_CR3","doi-asserted-by":"crossref","unstructured":"Holt E (2022) Growing concern over Ukrainian refugee health. Lancet 399(10331):1213\u20131214","DOI":"10.1016\/S0140-6736(22)00568-2"},{"key":"5191_CR4","unstructured":"External power restored to Ukraine\u2019s Zaporizhzhia nuclear plant, IAEA says. Reuters. 2022. Available from: https:\/\/www.reuters.com\/world\/europe\/external-power-restored-ukraines-zaporizhzhia-nuclear-plant-iaea-2022-11-05\/. Accessed 14 Nov 2022"},{"key":"5191_CR5","unstructured":"Nuclear Power in Ukraine | Ukrainian Nuclear Energy - World Nuclear Association. World-nuclear.org. 2022. Available from: https:\/\/world-nuclear.org\/information-library\/country-profiles\/countries-t-z\/ukraine.aspx. Accessed\u00a0\u00a024 Mar 2022"},{"key":"5191_CR6","unstructured":"Ukraine: Russia-Ukraine War and Nuclear Energy - World Nuclear Association. World-nuclear.org. 2022 Available from: https:\/\/world-nuclear.org\/information-library\/country-profiles\/countries-t-z\/ukraine-russia-war-and-nuclear-energy.aspx. Accessed\u00a025 Mar 2022"},{"key":"5191_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1749-6632.2009.04822.x","volume":"1181","author":"AB Nesterenko","year":"2009","unstructured":"Nesterenko AB, Nesterenko VB, Yablokov AV, Chapter II (2009) Consequences of the chernobyl catastrophe for public health. Ann N Y Acad Sci 1181:31\u2013220. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04822.x","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"5191_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1470-2045(02)00727-1","volume":"3","author":"K Moysich","year":"2002","unstructured":"Moysich K, Menezes R, Michalek A (2002) Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet Oncol 3(5):269\u2013279","journal-title":"Lancet Oncol"},{"key":"5191_CR9","unstructured":"Update 10 \u2013 IAEA Director General Statement on Situation in Ukraine | IAEA. IAEA 2022. Available from: https:\/\/www.iaea.org\/newscenter\/pressreleases\/update-10-iaea-director-general-statement-on-situation-in-ukraine.Accessed 25 Mar 2022"},{"key":"5191_CR10","doi-asserted-by":"crossref","unstructured":"Castelvecchi D (2022) Ukraine nuclear power plant attack: scientists assess the risks. Nature\u00a0","DOI":"10.1038\/d41586-022-00660-z"},{"key":"5191_CR11","unstructured":"Institut de radioprotection et de s\u00fbret\u00e9 nucl\u00e9aire. 2022. Available from: https:\/\/www.irsn.fr\/EN\/newsroom\/News\/Documents\/IRSN_Information-Report_Situation-of-nuclear-facilities-in-Ukraine_20220301.pdf. Accessed\u00a025 Mar 2022"},{"key":"5191_CR12","unstructured":"The Fukushima Daiichi Accident | IAEA. Iaea.org. 2022. Available from:https:\/\/www.iaea.org\/publications\/10962\/the-fukushima-daiichi-accident.\u00a0Accessed\u00a026 Mar 2022"},{"key":"5191_CR13","unstructured":"Advancing U.S. Resilience to a Nuclear Catastrophe. Center for health security. 2022. Available from: https:\/\/www.centerforhealthsecurity.org\/our-work\/events-archive\/2011_resilience_nuc_catastrophe\/nuke-res_cnf_rpt.pdf. Accessed\u00a026 Mar 2022"},{"issue":"9992","key":"5191_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(15)61106-0","volume":"386","author":"A Hasegawa","year":"2015","unstructured":"Hasegawa A, Tanigawa K, Ohtsuru A, Yabe H, Maeda M, Shigemura J et al (2015) Health effects of radiation and other health problems in the aftermath of nuclear accidents, with an emphasis on Fukushima. The Lancet 386(9992):479\u2013488","journal-title":"The Lancet"},{"issue":"5","key":"5191_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1001\/jama.1987.03400050067029","volume":"258","author":"R Gale","year":"1987","unstructured":"Gale R (1987) Immediate Medical Consequences of Nuclear Accidents. JAMA 258(5):625\u2013628","journal-title":"JAMA"},{"issue":"9","key":"5191_CR16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.7326\/0003-4819-109-9-730","volume":"109","author":"R Champlin","year":"1988","unstructured":"Champlin R, Kastenberg W, Gale R (1988) Radiation accidents and nuclear energy: medical consequences and therapy. Ann Intern Med 109(9):730","journal-title":"Ann Intern Med"},{"issue":"20","key":"5191_CR17","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1056\/NEJMra000365","volume":"346","author":"F Mettler","year":"2002","unstructured":"Mettler F, Voelz G (2002) Major radiation exposure \u2014 what to expect and how to respond. N Engl J Med 346(20):1554\u20131561","journal-title":"N Engl J Med"},{"issue":"9992","key":"5191_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(15)61167-9","volume":"386","author":"K Kamiya","year":"2015","unstructured":"Kamiya K, Ozasa K, Akiba S, Niwa O, Kodama K, Takamura N et al (2015) Long-term effects of radiation exposure on health. Lancet 386(9992):469\u2013478","journal-title":"Lancet"},{"issue":"4","key":"5191_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2188\/jea.JE20170321","volume":"28","author":"K Ozasa","year":"2018","unstructured":"Ozasa K, Grant E, Kodama K (2018) Japanese legacy cohorts: the life span study atomic bomb survivor cohort and survivors\u2019 offspring. J Epidemiol 28(4):162\u2013169","journal-title":"J Epidemiol"},{"key":"5191_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0002-9343(52)90285-4","volume":"13","author":"JH Folley","year":"1952","unstructured":"Folley JH, Borges W, Yamawaki T (1952) Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki. Japan Am J Med 13:311\u2013321","journal-title":"Japan Am J Med"},{"key":"5191_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1200\/JCO.2010.31.3080","volume":"29","author":"M Iwanaga","year":"2011","unstructured":"Iwanaga M, Hsu W-L, Soda M et al (2011) Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. J Clin Oncol 29:428\u2013434","journal-title":"J Clin Oncol"},{"key":"5191_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1667\/RR2629.1","volume":"177","author":"K Ozasa","year":"2012","unstructured":"Ozasa K, Shimizu Y, Suyama A et al (2012) Studies of the mortality of atomic bomb survivors, Report 14, 1950\u20132003: an overview of cancer and noncancer diseases. Radiat Res 177:229\u2013243","journal-title":"Radiat Res"},{"key":"5191_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1667\/RR0763.1","volume":"168","author":"DL Preston","year":"2007","unstructured":"Preston DL, Ron E, Tokuoka S et al (2007) Solid cancer incidence in atomic bomb survivors: 1958\u20131998. Radiat Res 168:1\u201364","journal-title":"Radiat Res"},{"key":"5191_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1667\/RR2975.1","volume":"178","author":"A Kesminiene","year":"2012","unstructured":"Kesminiene A, Evrard A-S, Ivanov VK et al (2012) Risk of thyroid cancer among chernobyl liquidators. Radiat Res 178:425\u2013436","journal-title":"Radiat Res"},{"key":"5191_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.clon.2011.01.510","volume":"23","author":"E Cardis","year":"2011","unstructured":"Cardis E, Hatch M (2011) The Chernobyl accident\u2014an epidemiological perspective. Clin Oncol (R Coll Radiol) 23:251\u2013260","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"5","key":"5191_CR26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/stem.16","volume":"27","author":"T Fliedner","year":"2009","unstructured":"Fliedner T, Chao N, Bader J, Boettger A, Case C, Chute J et al (2009) Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S.\/European Consultation Workshop. Stem Cells 27(5):1205\u20131211","journal-title":"Stem Cells"},{"issue":"1","key":"5191_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/asheducation-2003.1.473","volume":"2003","author":"N Dainiak","year":"2003","unstructured":"Dainiak N, Waselenko J, Armitage J, MacVittie T, Farese A (2003) The hematologist and radiation casualties. Hematology 2003(1):473\u2013496","journal-title":"Hematology"},{"key":"5191_CR28","unstructured":"Running the European Network of Biological and retrospective Physical dosimetry. RENEB. 2022. Available from: https:\/\/www.reneb.net\/. Accessed\u00a014 Nov 2022"},{"key":"5191_CR29","unstructured":"REMM - Radiation Emergency Medical Management. REMM. 2022. Available from: https:\/\/remm.hhs.gov\/.\u00a0 Accessed 27 Mar 2022"},{"key":"5191_CR30","unstructured":"Radiation Injury Treatment Network. RITN. 2022. Available from:https:\/\/ritn.net\/. Accessed\u00a027 Mar 2022"},{"issue":"10","key":"5191_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00277-006-0153-x","volume":"85","author":"N Gorin","year":"2006","unstructured":"Gorin N, Fliedner T, Gourmelon P, Ganser A, Meineke V, Sirohi B et al (2006) Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol 85(10):671\u2013679","journal-title":"Ann Hematol"},{"volume-title":"Medical management of radiation accidents: manual on the acute radiation syndrome","year":"2001","key":"5191_CR32","unstructured":"Fliedner TM, Friesecke I, Beyrer K (eds) (2001). British Institute of Radiology"},{"issue":"12","key":"5191_CR33","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1182\/blood-2008-04-150243","volume":"111","author":"T Fliedner","year":"2008","unstructured":"Fliedner T, Powles R, Sirohi B, Niederwieser D (2008) Radiologic and nuclear events: the METREPOL severity of effect grading system. Blood 111(12):5757\u20135758","journal-title":"Blood"},{"key":"5191_CR34","unstructured":"Nuclear Accident Committee Pocket Guide. EBMT. 2022. Available from: https:\/\/www.ebmt.org\/sites\/default\/files\/2018-03\/EBMT%20Nuclear%20Accident%20Committee%20Pocket%20Guide%202017.pdf. Accessed\u00a025 Mar 2022"},{"issue":"2","key":"5191_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1667\/RR14612.1","volume":"188","author":"M Port","year":"2017","unstructured":"Port M, Pieper B, Knie T, D\u00f6rr H, Ganser A, Graessle D et al (2017) Rapid prediction of hematologic acute radiation syndrome in radiation injury patients using peripheral blood cell counts. Radiat Res 188(2):156\u2013168","journal-title":"Radiat Res"},{"issue":"4","key":"5191_CR36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/HP.0000000000001353","volume":"120","author":"M Port","year":"2021","unstructured":"Port M, Haupt J, Ostheim P, Majewski M, Combs SE, Atkinson M et al (2021) Software tools for the evaluation of clinical signs and symptoms in the medical management of acute radiation syndrome-a five-year experience. Health Phys 120(4):400\u2013409","journal-title":"Health Phys"},{"issue":"12","key":"5191_CR37","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1182\/blood-2008-01-134817","volume":"111","author":"DM Weinstock","year":"2008","unstructured":"Weinstock DM, Case C, Bader JL, Chao NJ, Coleman CN, Hatchett RJ (2008) Radiologic and nuclear events: contingency planning for hematologists\/oncologists. Blood 111(12):5440\u20135445","journal-title":"Blood"},{"issue":"3","key":"5191_CR38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/dmp.2011.68","volume":"5","author":"N Dainiak","year":"2011","unstructured":"Dainiak N, Gent R, Carr Z, Schneider R, Bader J, Buglova E et al (2011) First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation. Disaster Med Public Health Prep 5(3):202\u2013212","journal-title":"Disaster Med Public Health Prep"},{"issue":"suppl_2","key":"5191_CR39","doi-asserted-by":"publisher","first-page":"ii54","DOI":"10.1093\/jrr\/rry004","volume":"59","author":"N Dainiak","year":"2018","unstructured":"Dainiak N (2018) Medical management of acute radiation syndrome and associated infections in a high-casualty incident. J Radiat Res 59(suppl_2):ii54\u2013ii64","journal-title":"J Radiat Res"},{"key":"5191_CR40","unstructured":"Cytokine administration triage guidelines for acute radiation syndrome (adult and pediatric). RITN. 2022. Available from: https:\/\/ritn.net\/workarea\/downloadasset.aspx?id=17179869221. Accessed\u00a027 Mar 2022"},{"issue":"12","key":"5191_CR41","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1056\/NEJM200209193471217","volume":"347","author":"R Powles","year":"2002","unstructured":"Powles R, Apperley J (2002) Major radiation exposure. N Engl J Med 347(12):944\u2013945","journal-title":"N Engl J Med"},{"key":"5191_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/stem.5530150738","volume":"15","author":"D Densow","year":"1997","unstructured":"Densow D, Kindler H, Baranov AE et al (1997) Criteria for selection of radiation accident victims for stem cell transplantation. Stem Cells 15:287\u2013297","journal-title":"Stem Cells"},{"key":"5191_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJM198907273210401","volume":"321","author":"A Baranov","year":"1989","unstructured":"Baranov A, Gale RP, Guskova A et al (1989) Bone marrow transplantation after the Chernobyl nuclear accident. N Engl J Med 321:205\u2013212","journal-title":"N Engl J Med"},{"key":"5191_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1259\/bjr\/31003240","volume":"27","author":"N Dainiak","year":"2005","unstructured":"Dainiak N, Ricks RC (2005) The evolving role of haematopoietic cell transplantation in radiation injury:potentials and limitations. BJR Suppl 27:169\u2013174","journal-title":"BJR Suppl"},{"key":"5191_CR45","unstructured":"Member Societies of WBMT - WBMT. WBMT. 2022. Available from: https:\/\/www.wbmt.org\/member-societies-of-wbmt\/. Accessed\u00a022 Mar 2022"},{"key":"5191_CR46","doi-asserted-by":"crossref","unstructured":"Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S (2021) One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica 107(5):1045\u20131053","DOI":"10.3324\/haematol.2021.279189"},{"issue":"6","key":"5191_CR47","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/01.HP.0000348460.61543.cf","volume":"98","author":"R Powles","year":"2010","unstructured":"Powles R, Sirohi B, Niederwieser D (2010) The role of the European haematologist in a large irradiation emergency: the European Blood and Marrow Transplantation Society (EBMT) Nuclear Accident Committee (NAC). Health Phys 98(6):810\u2013814","journal-title":"Health Phys"},{"key":"5191_CR48","unstructured":"Nuclear Accident Committee. EBMT. 2022. Available from: https:\/\/www.ebmt.org\/nuclear-accident-committee. Accessed\u00a023 Mar 2022"},{"key":"5191_CR49","unstructured":"WHO Radiation Emergency Medical Preparedness and Assistance Network - REMPAN Directory 2022. World Health Organization. 2022. Available from: https:\/\/www.who.int\/publications\/m\/item\/who-radiation-emergency-medical-preparedness-and-assistance-network---rempan-directory-2022. Accessed\u00a025 Mar 2022"},{"key":"5191_CR50","unstructured":"Global Emergencies \/ Nuclear Accident Management Committee - WBMT. WBMT. 2022. Available from: https:\/\/www.wbmt.org\/standing-committees\/nuclear-accident-management-committee\/. Accessed\u00a023 Mar 2022"},{"key":"5191_CR51","doi-asserted-by":"crossref","unstructured":"Saccardi R, McGrath E, Snowden JA (2019) JACIE Accreditation of HSCT Programs. In: Carreras E, Dufour C, Mohty M, et al., editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies. 7th edition. Cham (CH): Springer. Chapter 5 pp 35\u201340","DOI":"10.1007\/978-3-030-02278-5_5"},{"key":"5191_CR52","unstructured":"FACT-JACIE International Standards for HEMATOPOIETIC CELLULAR THERAPY Product Collection, Processing, and Administration. Eighth edition EBMT. 2022. Available from: https:\/\/www.ebmt.org\/sites\/default\/files\/2021-12\/STS_5_2_041_FACTJACIE%20Standards%20Eighth%20Edition_8_1_R2_12142021_ForWeb.pdf. Accessed 25 Mar 2022"},{"key":"5191_CR53","unstructured":"JACIE Accreditation. EBMT. 2022. Available from: https:\/\/www.ebmt.org\/jacie-accreditation. Accessed\u00a025 Mar 2022"},{"key":"5191_CR54","unstructured":"FACT Accredited Institutions. FACT. 2022. Available from: https:\/\/accredited.factwebsite.org\/. Accessed\u00a025 Mar 2022"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05191-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05191-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05191-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T10:04:49Z","timestamp":1710410689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05191-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["5191"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05191-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"9 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"MK: Honoraria and Advisory board from Gilead. DW: Research Funding from FATE therapeutics and Incyte. SKH: Honoraria from Pfizer, Novartis, Janssen, Therakos Mallinckrodt, Sanofi, Roche. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}